Reig Jofre's nutritional supplements line expands its product portfolio
Forté Pharma expands its energy and health segments with the launch of eight references in the French market, as a result of its product development strategy.
Forté Pharma, Reig Jofre’s nutritional supplements line, launches in France, its home market, eight references in the energy and health segments, as a result of its strategy of development and extension of their portfolios in comparison with the weight control segment, with a higher seasonality and exposure to the evolution of consumption in Europe.
Forté Pharma has well-consolidated positioning products in the energy segment such as the Vitalité 4G line, with more than 10 years of market presence and sales leader in its category, which extends its range with Vitalité 4G Shot, concentrated spray in ginseng, guarana, ginger and royal jelly to combat temporary fatigue and lack of energy and with Vitalité 4G Senior enriched with ginkgo biloba tostrengthen brain functions, improve concentration, combat memory loss, promote cerebral blood circulation and also enriched with astragalus, known antioxidant that increases physical and mental endurance, helps to reinforce the defenses and has an anti-aging activity.
Likewise, the jelly line extends its range with Gelée Royale Dynamisant, nutritious and energetic concentrate based on royal jelly, mate, acerola and pollen, designed to strengthen the defenses and combat fatigue.
The energy segment, growing in the market for nutritional supplements in France, reaches sales of more than 170 million euros, of which Forté Pharma contributes 6 million euros, with more than 3,000 points of sale between pharmacies and parapharmacies.
In the health segment, Forté Pharma expands its line of products with five references, Forté Rub, the first nutritional supplement whose unique formula based on chronobiology, combines six natural extracts to combat common cold symptoms through a specific formula for the day to clear respiratory tract, eliminates nasal congestion, avoids coughing and restores energy; and another formula for the night that relieves throat, clears nose and fights fever to improve respiratory comfort and sleep better. Propolis Spray, highly concentrated formula for maximum effectiveness in throat care and Propolis Spray Junior, sweet formula specially adapted for children. Co-Enzyme Q10, potent antioxidant indicated in the cell protection from the harmful effects of free radicals. The range of jelly beans MiniGum for children from three years of age to help them stay in shape and improve their defenses, rest and growth, launches a new reference enriched with fiber to promote intestinal transit.
Nowadays the portfolio of Forte Pharma is organized into four segments: slimming (30% of its total sales), energy (35%), health (22%) and beauty (13%) at the end of September 2017.
Reig Jofre focused much of their efforts on enhancing the geographical diversification of Forte Pharma and expanding its product portfolio through direct support of its marketing strategy.
The positive evolution of energy and health segments in recent years made possible counteract the effect of the contraction suffered by the nutritional supplements industry for weight control in France, so the company will continue to work in this line of development.
In terms of geographic diversification, the presence of the brand in markets outside France went from 22% in 2006 to 33% at the end of 2017. At present, the marketing of Forte Pharma products is conducted mostly in Europe through own sales network. Forte Pharma’s home market, and still today the first market of the brand, is France, which concentrated 67% of sales, followed by Forte Pharma Iberica (Spain and Portugal) and Benelux, with 13% respectively, and 7% in the rest of the world.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance